SS (Sterre) Bour

Erasmus School of Health Policy & Management

PhD candidate | Health Technology Assessment (HTA)

Elise Van Mulligen, Sterre S. Bour, Lucas M.A. Goossens, Pascal Hendrik Pieter De Jong, Maureen Rutten-Van Mölken & Annette Van Der Helm-Van Mil (2024) - Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective?: A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial - Annals of the rheumatic diseases - doi: 10.1136/ard-2024-226286 - [link]
Sterre S. Bour, Lena H.A. Raaijmakers, Erik W.M.A. Bischoff, Lucas M.A. Goossens & Maureen P.M.H. Rutten-van Mölken (2023) - How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands? - International Journal of Environmental Research and Public Health, 20 (5) - doi: 10.3390/ijerph20053857 - [link]
Marcel Jonker, Esther Grob, Jorien Veldwijk, Lucas Goossens, S Bour & MPMH Rutten-van Mölken (2020) - COVID-19 contact-tracing apps: predicted uptake in the Netherlands based on a discrete choice experiment - JMIR mHealth and uHealth, 8 (10) - doi: 10.2196/20741 - [link]